Verition Fund Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 15,113 shares of KALV stock, worth $169,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,113Holding current value
$169,265% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding KALV
# of Institutions
120Shares Held
48MCall Options Held
71.8KPut Options Held
26.3K-
Vr Adviser, LLC New York, NY6.25MShares$70 Million8.08% of portfolio
-
Tang Capital Management LLC San Diego, CA4.22MShares$47.3 Million6.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.19MShares$47 Million2.06% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$41.3 Million2.56% of portfolio
-
Capital World Investors Los Angeles, CA3.23MShares$36.1 Million0.01% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $276M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...